Marfan Syndrome

• Fibrillin-1 deficiency and extracellular matrix disruption: Fibrillin-1 is essential for forming microfibrils—cable-like structures that provide tensile strength to tissues and serve as a scaffold for elastin deposition. Mutations in FBN1 (affecting ~75% of the protein sequence) result in production of abnormal fibrillin-1 or reduced protein levels. This deficiency compromises the structural integrity of connective tissues throughout the body, particularly in tissues under mechanical stress such as the aorta, ligaments, lens zonules, and bone. The weakened extracellular matrix cannot properly resist the hemodynamic forces exerted on the aorta, leading to progressive dilatation. Similarly, degradation of ligamentous support in the spine results in scoliosis, and disruption of ocular zonular fibers causes lens dislocation (ectopia lentis).

• TGF-β signaling dysregulation and vascular remodeling: Fibrillin-1 directly binds and sequesters latent TGF-β in the extracellular matrix. In Marfan syndrome, decreased fibrillin-1 results in excessive liberation of active TGF-β, particularly within the aortic wall. Elevated TGF-β signaling through the ALK5/Smad2/3 pathway promotes excessive smooth muscle proliferation, increased proteolytic enzyme (matrix metalloproteinase) expression, and enhanced collagen remodeling in the aortic media. This paradoxically leads to both excessive matrix degradation and pathological smooth muscle proliferation, resulting in medial degeneration and aortic wall weakening despite increased collagen deposition. This TGF-β-mediated mechanism is crucial because it explains why aortic disease develops progressively even in adolescence, and why ARBs (which block ALK5 signaling) are effective at halting progression.

• Skeletal manifestations from impaired osteoblast function: Fibrillin-1 is abundant in bone and plays a role in osteoblast differentiation and bone matrix organization. Deficient fibrillin-1 impairs mechanical signal transduction in bone, resulting in reduced bone mineralization and abnormal skeletal development. The excessive TGF-β signaling in bone also promotes osteoclast activation and bone resorption. These combined effects lead to the characteristic skeletal features: tall stature (from impaired feedback inhibition of growth hormone signaling), arachnodactyly (disproportionately long fingers from abnormal metacarpal growth), pectus abnormalities (from disrupted costal cartilage development), and scoliosis (from weakened spinal ligaments and impaired vertebral development).

• Ocular lens zonule disruption: The ciliary zonule—delicate fibrillar structures suspending the lens—is composed primarily of fibrillin-1. Mutations causing fibrillin deficiency or production of non-functional fibrillin render the zonules structurally incompetent to withstand the tensile forces during accommodation and eye movement. This results in progressive weakness and eventual rupture of zonular fibers, leading to ectopia lentis. The lens dislocates typically in a superotemporal direction (upward and outward), which is pathognomonic for Marfan syndrome and distinguishes it from homocystinuria (where dislocation is inferonasal—downward and inward).

• FBN1 gene mutations (autosomal dominant inheritance): The FBN1 gene spans 110 kilobases on chromosome 15q21 with 65 exons. Over 3,000 distinct mutations have been identified, including missense mutations, nonsense mutations, small insertions/deletions, and splice site mutations. Most mutations demonstrate incomplete penetrance and variable expressivity, meaning that identical mutations may produce different clinical severity even within families. Approximately 25-30% of cases represent de novo mutations with no family history, reflecting the relatively high mutation rate in this large gene. The type of mutation and location within the gene can influence severity: cysteine substitutions in fibrillin-1's EGF-like domains are particularly severe, and mutations in exons 24-32 correlate with more aggressive aortic disease. Genetic testing via sequencing is the gold standard for diagnosis but may not identify mutations in all clinically diagnosed patients (~10% have negative genetic testing despite meeting clinical diagnostic criteria).

• Familial clustering and inheritance pattern: Marfan syndrome exhibits autosomal dominant inheritance with approximately 25-30% de novo mutation rate. Affected individuals have a 50% risk of transmitting the mutation to each offspring, regardless of sex. Prenatal and preimplantation genetic diagnosis is available for families with known mutations. Homozygous Marfan syndrome is extremely rare but causes severe, typically neonatal-lethal disease.

• Genetic modifiers and phenotypic heterogeneity: Even among patients with identical FBN1 mutations, clinical severity varies considerably, suggesting that genetic background, other polymorphisms, and environmental factors modify disease expression. Polymorphisms in genes involved in TGF-β signaling (such as TGFBR2) may influence the rate of aortic progression. This genetic heterogeneity has important prognostic implications and explains why family members with the same mutation may have strikingly different clinical courses.

• Skeletal abnormalities (most visible and recognizable features): Patients typically present with disproportionate tall stature with an arm-span-to-height ratio greater than 1.05 (normally ≤1.03), resulting from increased long bone length relative to trunk length. This occurs because fibrillin-1 deficiency impairs negative feedback regulation of growth hormone secretion, allowing prolonged epiphyseal growth. Arachnodactyly (abnormally long, slender fingers) is so characteristic that the thumb sign and wrist sign are part of diagnostic criteria: the thumb sign is positive when the adducted thumb extends beyond the ulnar border of the closed fist; the wrist sign is positive when the thumb and fifth finger overlap when encircling the wrist with the opposite hand. Patients frequently have high-arched palate, dental crowding, and retrognathia from abnormal facial bone development. Pectus deformities occur in approximately 60% of patients, including pectus carinatum (pigeon breast, anterior protrusion) or pectus excavatum (funnel chest, anterior depression); these deformities increase in severity during growth spurts and may impair pulmonary and cardiac function. Scoliosis develops in 60% of patients, often severe (>40° in 10% of cases), from weakness of spinal ligaments and abnormal vertebral development; it can progress rapidly during adolescence and may require surgical correction. Hypermobility of joints occurs due to ligamentous laxity but is typically less severe than in Ehlers-Danlos syndrome. Kyphosis may develop, particularly in the thoracolumbar region.

• Cardiovascular manifestations (most life-threatening): Aortic root dilatation is the hallmark cardiovascular finding, occurring progressively from childhood onward and affecting 60-80% of adult patients. The normal aortic root diameter at the sinuses of Valsalva is approximately 3-3.5 cm; in Marfan syndrome, progressive dilatation can exceed 5-6 cm or more. The dilated aorta is predisposed to acute aortic dissection (typically Type A, involving the ascending aorta), which may occur suddenly and catastrophically, often without preceding symptoms, and represents the most common cause of death in Marfan syndrome. Aortic dissection can present with sudden-onset severe tearing chest pain radiating to the back, acute dyspnea, syncope, or sudden cardiac death. Aortic regurgitation (AR) develops secondary to aortic root dilatation, initially causing widened pulse pressure with a hyperdynamic precordium and bounding pulses, but eventually resulting in acute or chronic left ventricular dysfunction. Mitral valve prolapse (MVP) occurs in approximately 80% of Marfan patients, usually with benign hemodynamic consequences but rarely progressing to severe mitral regurgitation; it presents with a late-systolic click and murmur. Some patients develop endocarditis on the prolapsed mitral valve, necessitating antibiotic prophylaxis in certain circumstances (though modern guidelines reserve this for high-risk patients). Progressive left ventricular dilatation and systolic dysfunction can develop from chronic AR or MVP-associated disease. Pulmonary artery dilatation may occur but is generally less severe than aortic involvement.

• Ocular manifestations: Ectopia lentis (lens dislocation) is highly specific for Marfan syndrome and occurs in approximately 50% of patients, typically manifesting in the first or second decade but sometimes appearing later. The subluxated or dislocated lens causes refractive error (myopia and astigmatism), blurred or double vision, and visual field defects when the lens dislocates across the visual axis. Zonular fibers may rupture acutely following minor ocular trauma or spontaneously, potentially precipitating phacolytic glaucoma or lens-particle glaucoma. Myopia is present in most Marfan patients (affecting >50%), independent of lens dislocation, likely from elongation of the posterior segment. Astigmatism is also common. Retinal detachment occurs in 5-10% of patients, particularly when zonular integrity is compromised. Iris transillumination defects (holes in the iris) may be present. Glaucoma can develop from various mechanisms including zonular weakness, lens dislocation into the anterior chamber, and primary angle-closure mechanisms.

• Pulmonary manifestations: Spontaneous pneumothorax occurs in 5-10% of Marfan patients, resulting from apical subpleural blebs or bullae that rupture; it typically presents with acute pleuritic chest pain and dyspnea. The recurrence rate is high (>20%), and recurrent pneumothorax may indicate need for pleurodesis or thoracic surgery. Sleep apnea may develop from palatal abnormalities and airway collapse. Restrictive lung disease can result from severe kyphoscoliosis, limiting chest wall excursion and ventilation.

• Cutaneous and skin manifestations: Patients often have striae atrophicae (stretch marks), which occur more readily than in the general population due to dermal fragility; these are broad, atrophic, and may occur without preceding weight gain. Skin hyperextensibility is less pronounced than in Ehlers-Danlos syndrome but may be apparent. Some patients develop aneurysms of medium-sized arteries beyond the aorta, though this is less common than aortic disease.

• Neurological manifestations: Dural ectasia (dural sac dilatation, particularly in the lumbosacral region) occurs in 60% of patients and may cause chronic back pain, neurologic claudication, or be asymptomatic. Enlargement of spinal nerve root sleeves can be visible on MRI. Rarely, severe dural ectasia causes neurologic compromise. Meningeal irritation from dural inflammation may occur. Marfan patients have a slight increased risk of learning disabilities and attention-deficit hyperactivity disorder (ADHD), though central nervous system structural abnormalities are uncommon.

• Revised Ghent Nosology (2010): The most widely used clinical diagnostic criteria for Marfan syndrome incorporate major and minor features across organ systems. The diagnosis is established when specific combinations of findings are present, with the strongest diagnostic power residing in features such as aortic root Z-score ≥2 (adjusted for age and body surface area) in combination with ectopia lentis, or aortic root Z-score ≥2 in combination with an FBN1 mutation, or specific combinations of skeletal features (family history of Marfan + ectopia lentis, or family history of Marfan + aortic root dilatation, or family history of Marfan + major skeletal features). The 2010 revision emphasized the primacy of aortic root dilatation and de-emphasized less specific skeletal features. Presence of a pathogenic FBN1 mutation definitively establishes Marfan diagnosis regardless of clinical features.

• Aortic root assessment (transthoracic echocardiography): Transthoracic echocardiography (TTE) is the first-line imaging modality for evaluating aortic root diameter. The diameter is measured at the level of the sinuses of Valsalva (where aortic dilatation is most pronounced), and the measurement is converted to a Z-score adjusted for age and body surface area; a Z-score ≥2.0 is considered dilated and a diagnostic major criterion. Serial echocardiograms should be performed annually in children and every 1-2 years in stable adults, with more frequent monitoring if aortic dilation is progressive. Transoesophageal echocardiography (TEE) provides superior visualization of the ascending aorta and descending aorta and is indicated if TTE is technically inadequate or if aortic dissection is suspected. Cardiac MRI and CT angiography offer excellent anatomic detail of the entire aorta and are useful for assessing the aortic arch, descending aorta, and detecting dissection; CT is preferred in acute settings when dissection is suspected.

• Genetic testing for FBN1 mutations: **DNA sequencing of the FBN1 gene** is the definitive diagnostic test and is indicated in all suspected Marfan cases. Given the large gene size (65 exons) and heterogeneity of mutations, comprehensive sequencing and deletion/duplication analysis are typically performed. Sequencing sensitivity is approximately 95-98% for pathogenic mutations, with 5-10% of clinically diagnosed patients having negative results despite fulfilling clinical criteria (likely due to mosaicism, incomplete penetrance, or misdiagnosis). Confirmation of a pathogenic mutation definitively establishes diagnosis and allows for genetic counseling and testing of relatives. Variants of uncertain significance (VUS) require careful interpretation and may necessitate functional studies or family segregation analysis.

• Ophthalmologic examination: Slit-lamp examination should be performed to assess for ectopia lentis, zonular defects, and other lens abnormalities. Ectopia lentis is highly specific for Marfan syndrome and is a major diagnostic criterion; when present with appropriate family history or aortic findings, it significantly increases diagnostic certainty. Dilated fundus examination screens for retinal detachment and assesses optic nerve health. Refraction and visual acuity testing document myopia and astigmatism. Ophthalmologic findings strongly support diagnosis when ectopia lentis is present.

• Skeletal assessment: Physical examination documenting arachnodactyly (thumb sign, wrist sign), tall stature with increased arm-span-to-height ratio, pectus deformity, and scoliosis is essential. Spine X-rays quantify scoliosis severity (Cobb angle). Chest X-ray may reveal pectus deformities and should be obtained as baseline imaging. Skeletal features are less specific than cardiovascular or ocular findings but contribute to overall diagnostic assessment.

• Dural ectasia screening: Lumbosacral MRI is recommended in all Marfan patients to assess for dural ectasia and detect any associated spinal cord compression

Acute aortic dissection (Stanford type A) — emergency

• Immediate stabilisation: per the 2022 ACC/AHA Aortic Disease Guideline, reduce aortic wall shear stress (dP/dt) before reducing pressure alone. Give an IV beta blocker (esmolol, or labetalol which also has alpha blockade) first, targeting heart rate control, then add a vasodilator (sodium nitroprusside) for residual hypertension. Adding a vasodilator before beta blockade causes reflex tachycardia and increases dP/dt, propagating the dissection. Opioid analgesia lowers sympathetic tone.
• Definitive management: type A dissection in Marfan syndrome is a surgical emergency — emergent open ascending aorta/root replacement. Uncomplicated type B dissection is managed medically with anti-impulse therapy; malperfusion, rupture, or refractory pain prompts intervention.

Chronic medical therapy to slow aortic growth

• Beta blockers: representative agent atenolol; reduce dP/dt and rate of aortic root dilatation. Long-standing first-line therapy endorsed by ACC/AHA.
• ARBs: losartan; blocks angiotensin II–driven TGF-β/ALK5 signalling in the media, the mechanism outlined above. Used as an alternative in beta-blocker intolerance or in combination; comparative trials showed similar aortic growth rates for the two classes.
• Blood pressure control and treatment of obstructive sleep apnoea, both of which raise aortic wall stress.

Prophylactic aortic root surgery

• Elective root replacement is recommended by ACC/AHA once the root reaches roughly 5.0 cm, and at smaller diameters with rapid growth, family history of dissection at small size, or planned pregnancy.
• Valve-sparing root replacement (David procedure) is preferred when leaflets are normal; a **composite valve-graft (Bentall)** is used when aortic regurgitation is severe, obligating lifelong anticoagulation with a mechanical prosthesis.

Contraindicated / avoid

• Fluoroquinolones — FDA warning for aortic aneurysm and dissection.
• Isometric exercise, heavy weightlifting, collision/contact sports, and competitive burst activity; stimulants and decongestants.
• ARBs/ACE inhibitors in pregnancy (fetotoxic) — switch to a beta blocker; ACOG and ACC/AHA advise pre-conception imaging and high-risk co-management.

Cardiovascular — the leading cause of death

• Acute type A aortic dissection / rupture (EMERGENCY): cystic medial degeneration from fibrillin-1 loss and TGF-β–driven matrix proteolysis leaves the media unable to resist wall stress. Signalled by sudden tearing chest pain radiating to the back, pulse or blood-pressure differential between arms, new diastolic murmur of aortic regurgitation, or syncope; mediastinal widening on chest radiograph.
• Cardiac tamponade or acute severe aortic regurgitation from proximal extension (EMERGENCY): hypotension, muffled heart sounds, or flash pulmonary oedema.
• Chronic aortic regurgitation → LV dilatation and heart failure: progressive root dilatation splays the leaflets; wide pulse pressure, bounding pulses, decrescendo diastolic murmur.
• Severe mitral regurgitation from myxomatous prolapse, and rarely infective endocarditis on the redundant leaflet.

Non-cardiac

• Tension pneumothorax (EMERGENCY): rupture of apical subpleural blebs; sudden pleuritic pain, dyspnoea, tracheal deviation, absent breath sounds — needle decompression before imaging.
• Lens dislocation into the anterior chamber with acute glaucoma, and retinal detachment (both ocular EMERGENCIES): zonular rupture; painful red eye with raised intraocular pressure, or painless curtain visual field loss with floaters/flashes.
• Progressive scoliosis and pectus deformity: restrictive lung disease and impaired cardiac filling.
• Dural ectasia: low back pain, postural headache from CSF leak; anaesthetically important because it causes failed or unpredictable spinal/epidural block.

Treatment-related

• Beta blockers: bradycardia, fatigue, exercise intolerance, bronchospasm in reactive airways.
• ARBs: hyperkalaemia, rise in creatinine, and fetal renal/skeletal toxicity if continued in pregnancy.
• Post-surgical: anastomotic pseudoaneurysm, prosthetic valve endocarditis, and — after a composite graft — anticoagulation-related bleeding and thromboembolism. Residual native aorta remains at risk, so distal aneurysm or dissection can occur years after successful root replacement; lifelong surveillance imaging is mandated by the 2022 ACC/AHA aortic disease guideline.

• Superotemporal lens dislocation = Marfan; inferonasal = homocystinuria: the single most tested ocular discriminator. Homocystinuria is autosomal recessive, adds intellectual disability, thromboembolism, and elevated homocysteine; Marfan patients have normal intelligence.
• Tall young athlete with sudden death or a marfanoid habitus: the single best next step is transthoracic echocardiography to measure the aortic root at the sinuses of Valsalva and calculate the Z-score — not chest radiograph, not genetic testing first.
• Suspected acute dissection in a stable patient: CT angiography of the chest is the first test; in the unstable patient, TEE at the bedside. Begin IV beta blockade before any vasodilator — nitroprusside first causes reflex tachycardia and extends the tear.
• Chronic therapy is a beta blocker (atenolol) or an ARB (losartan) to reduce dP/dt and TGF-β signalling. Per ACC/AHA, prophylactic root replacement is offered well before dissection occurs — dissection risk tracks with diameter, so asymptomatic dilatation is still an operative indication.
• Mitral valve prolapse is the most common valvular lesion, but aortic root dilatation with regurgitation is what kills — do not let a mid-systolic click distract from the aorta.
• Avoid fluoroquinolones (FDA aortic dissection warning), isometric/heavy resistance exercise and contact sports, and ACE inhibitors/ARBs in pregnancy. Pregnancy itself is a high-risk state for dissection (peripartum and third trimester).
• The classic distractors: Loeys-Dietz (TGFBR1/2, bifid uvula, arterial tortuosity, hypertelorism), vascular Ehlers–Danlos (COL3A1, thin translucent skin, hollow organ and mid-sized artery rupture, no ectopia lentis), and MEN2B (marfanoid habitus with mucosal neuromas and medullary thyroid carcinoma).
• Screen first-degree relatives with echocardiography and, when the family FBN1 variant is known, targeted genetic testing — autosomal dominant with 50% transmission and ~25–30% de novo mutations.